FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108783044> ?p ?o ?g. }

• W2108783044 endingPage "136" @default.
• W2108783044 startingPage "117" @default.
• W2108783044 abstract "In cardiorenal syndrome (CRS) type 2, chronic heart failure (HF) results in the onset or progression of chronic kidney disease (CKD). Examples of CRS type 2 (CRS2) include progressive CKD resulting from chronic HF in congenital or acquired heart disease or from repeated bouts of acute decompensated HF. Animal data and clinical studies indicate that extended periods of chronic HF result in altered renal hemodynamics followed by progressive renal pathology. Experimental and clinical data indicate that CRS2 is characterized by mild to moderate proteinuria, a progressive decline of glomerular filtration rate, and an elevated expression of renal injury biomarkers. Important pathophysiological triggers of renal disease progression include chronic increases in renal venous pressure, maladaptive activation of the renin-angiotensin-aldosterone axis and the sympathetic nervous system, as well as a chronic inflammatory state. Intrarenal oxidative stress and proinflammatory signaling precipitate structural injury, including glomerulosclerosis and tubulointerstitial fibrosis. Yet, clinical interventional trials that directly test the impact of renin-angiotensin system antagonists and β-blockers on the progression of CKD in CRS2 are lacking. Secondary analyses of trials designed to assess the impact of these agents on cardiovascular endpoints have failed to show a consistent benefit regarding renal functional parameters. In contrast, left ventricular assist device placement and cardiac resynchronization therapy in HF patients consistently improved renal function, suggesting a marked potential for reversibility in many cases of CRS2. Future research should be directed towards the evaluation of novel biomarkers to improve the diagnosis, severity grading as well as our understanding of the pathophysiology of CRS2. In addition, there is a need for interventional trials in HF patients to address long-term renal endpoints incorporating clinical information and measures of renal function as well as renal injury." @default.
• W2108783044 created "2016-06-24" @default.
• W2108783044 creator A5008382551 @default.
• W2108783044 creator A5021022035 @default.
• W2108783044 creator A5030559488 @default.
• W2108783044 creator A5069247258 @default.
• W2108783044 creator A5071954771 @default.
• W2108783044 creator A5076403607 @default.
• W2108783044 creator A5085792074 @default.
• W2108783044 date "2013-01-01" @default.
• W2108783044 modified "2023-10-15" @default.
• W2108783044 title "Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)" @default.
• W2108783044 cites W1894025993 @default.
• W2108783044 cites W1971876589 @default.
• W2108783044 cites W1976299512 @default.
• W2108783044 cites W1977511738 @default.
• W2108783044 cites W1984421771 @default.
• W2108783044 cites W1991662102 @default.
• W2108783044 cites W1997490882 @default.
• W2108783044 cites W1998536767 @default.
• W2108783044 cites W1998846386 @default.
• W2108783044 cites W2002747645 @default.
• W2108783044 cites W2011077698 @default.
• W2108783044 cites W2011726320 @default.
• W2108783044 cites W2012631324 @default.
• W2108783044 cites W2018065665 @default.
• W2108783044 cites W2019440040 @default.
• W2108783044 cites W2021690806 @default.
• W2108783044 cites W2023334382 @default.
• W2108783044 cites W2041413026 @default.
• W2108783044 cites W2043609912 @default.
• W2108783044 cites W2048396190 @default.
• W2108783044 cites W2049459862 @default.
• W2108783044 cites W2051348710 @default.
• W2108783044 cites W2052945040 @default.
• W2108783044 cites W2053766600 @default.
• W2108783044 cites W2054191916 @default.
• W2108783044 cites W2074522859 @default.
• W2108783044 cites W2084861006 @default.
• W2108783044 cites W2088741159 @default.
• W2108783044 cites W2088782509 @default.
• W2108783044 cites W2095491035 @default.
• W2108783044 cites W2104402487 @default.
• W2108783044 cites W2108879552 @default.
• W2108783044 cites W2110418992 @default.
• W2108783044 cites W2110802587 @default.
• W2108783044 cites W2111732405 @default.
• W2108783044 cites W2115933163 @default.
• W2108783044 cites W2120715438 @default.
• W2108783044 cites W2122553381 @default.
• W2108783044 cites W2122625788 @default.
• W2108783044 cites W2122726836 @default.
• W2108783044 cites W2135844589 @default.
• W2108783044 cites W2139489208 @default.
• W2108783044 cites W2140879596 @default.
• W2108783044 cites W2144350847 @default.
• W2108783044 cites W2147155927 @default.
• W2108783044 cites W2153028995 @default.
• W2108783044 cites W2154193616 @default.
• W2108783044 cites W2154855956 @default.
• W2108783044 cites W2159513257 @default.
• W2108783044 cites W2160109802 @default.
• W2108783044 cites W2160176956 @default.
• W2108783044 cites W2161388092 @default.
• W2108783044 cites W2164705414 @default.
• W2108783044 cites W2164852092 @default.
• W2108783044 cites W2165817472 @default.
• W2108783044 cites W2167939344 @default.
• W2108783044 cites W2168492354 @default.
• W2108783044 cites W2169268865 @default.
• W2108783044 cites W2169446771 @default.
• W2108783044 cites W2323458614 @default.
• W2108783044 cites W1968741675 @default.
• W2108783044 cites W2340166479 @default.
• W2108783044 cites W3149800922 @default.
• W2108783044 doi "https://doi.org/10.1159/000349968" @default.
• W2108783044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23689659" @default.
• W2108783044 hasPublicationYear "2013" @default.
• W2108783044 type Work @default.
• W2108783044 sameAs 2108783044 @default.
• W2108783044 citedByCount "91" @default.
• W2108783044 countsByYear W21087830442013 @default.
• W2108783044 countsByYear W21087830442014 @default.
• W2108783044 countsByYear W21087830442015 @default.
• W2108783044 countsByYear W21087830442016 @default.
• W2108783044 countsByYear W21087830442017 @default.
• W2108783044 countsByYear W21087830442018 @default.
• W2108783044 countsByYear W21087830442019 @default.
• W2108783044 countsByYear W21087830442020 @default.
• W2108783044 countsByYear W21087830442021 @default.
• W2108783044 countsByYear W21087830442022 @default.
• W2108783044 countsByYear W21087830442023 @default.
• W2108783044 crossrefType "book-chapter" @default.
• W2108783044 hasAuthorship W2108783044A5008382551 @default.
• W2108783044 hasAuthorship W2108783044A5021022035 @default.
• W2108783044 hasAuthorship W2108783044A5030559488 @default.
• W2108783044 hasAuthorship W2108783044A5069247258 @default.
• W2108783044 hasAuthorship W2108783044A5071954771 @default.

• next